Celina Monteiro Abreu

Medicine & Life Sciences

1. HIV 100%
2. HIV-1 95%
3. Mozambique 85%
4. Simian Immunodeficiency Virus 63%
5. Trypanosomatina 49%
6. Macrophages 49%
7. Macaca 43%
8. Peptide Hydrolases 40%
9. Viruses 37%
10. RNA-Directed DNA Polymerase 37%
11. Mutation 36%
12. Drug Resistance 30%
13. ingenol 27%
14. Myeloid Cells 27%
15. Viral Load 27%
16. Monocytes 27%
17. T-Lymphocytes 25%
18. Enfuvirtide 23%
19. Brain 20%
20. Human T-lymphotropic virus 1 18%
21. Therapeutics 18%
22. Human immunodeficiency virus 1 reverse transcriptase 18%
23. dolabellane 16%
24. Serine Proteases 16%
25. Diterpenes 16%
26. Reverse Transcriptase Inhibitors 16%
27. Acquired Immunodeficiency Syndrome 15%
28. Infections 14%
29. HIV Infections 14%
30. Neurocognitive Disorders 13%
31. Brazil 13%
32. In Vitro Techniques 13%
33. Virus Diseases 13%
34. Protease Inhibitors 12%
35. Emetine 11%
36. p31 integrase protein, Human immunodeficiency virus 1 11%
37. Euphorbia 11%
38. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine 11%
39. Integrase Inhibitors 11%
40. Nelfinavir 10%
41. Microglia 10%
42. SARS Virus 10%
43. Metalloproteases 10%
44. Ribonuclease H 10%
45. Integrases 10%
46. Feline Immunodeficiency Virus 10%
47. quinoline 10%
48. HIV-2 10%
49. Didanosine 10%
50. Deltaretrovirus 10%